Key opinion leaders in MS provide closing thoughts on the future of MS treatment including digital therapeutics, new generics, and pipeline drugs on the horizon. Neil Minkoff, MD: I’m going to open it ...

Myelocortical multiple sclerosis (MCMS) is a new subtype of multiple sclerosis (MS). It’s the first kind of MS known to cause nerve cell loss without damaging the myelin in your cerebral white matter.

Ocrelizumab is one of three B-cell therapies approved by the FDA to treat MS. This medicine sticks to B cells and keeps them from causing damage. It has the approval to treat: Clinically isolated ...

Fatigue or low energy is a common symptom of multiple sclerosis (MS). Traditional MS treatment, self-care, and complementary management strategies may help boost your energy and feel less tired.

If you’ve recently been diagnosed with multiple sclerosis (MS), chances are you have the relapsing-remitting form of the disease (often abbreviated as RRMS). This form of MS is characterized by ...